Perfil
Laetitia Szaller is currently working as the General Counsel & Head-Compliance at Egetis Therapeutics AB.
Previously, she worked as the VP-Business Development & General Counsel at AM-Pharma BV from 2020 to 2023.
Cargos activos de Laetitia Szaller
| Empresas | Cargo | Inicio |
|---|---|---|
| EGETIS THERAPEUTICS AB | Oficial de Cumplimiento | 22/12/2023 |
Antiguos cargos conocidos de Laetitia Szaller.
| Empresas | Cargo | Fin |
|---|---|---|
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Consejero General | 01/08/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Laetitia Szaller